News

AB-CT is excited to announce its participation in the upcoming 74th Annual Meeting of the Bayerischer Röntgenkongress (Bavarian Radiology Congress), taking place from October 5th to 7th in Landshut.
Attendees are invited to visit our booth #38, where we will be co-presenting with our esteemed partner, EXAMION.

Engage with our team of experts and gain valuable insights into the revolutionary nu:view breast CT system.

nu:view breast CT offers a range of exceptional features, designed to elevate the standard of diagnostic imaging:

• True 3D Imaging with high isotropic spatial resolution for precise diagnostics.
• Superimposition-free Imaging of soft tissue.
• Dose-Efficient Photon Counting Technology for optimal image acquisition.
• Compression-Free Examination for increased patient comfort.
• Fast Scan Times as quick as 7 to 12 second.
• Intuitive User Interface.

AB-CT is enthusiastic about sharing their knowledge, answering any questions, and exploring how these innovative solutions can enrich your medical practice.

We are pleased to announce its participation in the forthcoming Annual Scientific Meeting, hosted by the esteemed European Society for Breast Imaging in Spain.

Scheduled from September 28th to 30th in Valencia, this congress will convene experts and professionals to engage in substantive discussions regarding the latest advancements and knowledge exchange within the realm of breast imaging. This event offers a valuable opportunity for networking, education, and the fostering of contributions to the ongoing progress in breast health.

In addition to visiting our Booth #L06, we cordially invite you to partake in the featured Session 7, scheduled for Saturday the 30th, commencing at 9:00 AM, which focuses on the topic: “Advanced imaging techniques for characterizing breast lesions.”

Esteemed breast imaging authority Prof. Dr. Dr. Andreas Boss, who has been utilizing nu:view breast CT technology since 2018, will provide profound insights into the cutting-edge technology and imaging capabilities associated with dedicated breast CT.

We eagerly anticipate the opportunity to connect with you at EUSOBI.

• September 28-30
• Valencia, Spain
• Breast CT session: September 30, 9:33 AM
• AB-CT Booth #L06

AB-CT welcomes new members to the management team and advisory board!

• Dr. Felix Althoff joins as Chief Innovation Officer (CINO), driving research and innovative product enhancements including spectral CT and biopsy applications.
• Dr. Daniel Kolditz continues as Chief Technology Officer (CTO), overseeing physics, purchasing, production, and service.

“Both are recognized experts in the field of breast CT technology and have been significantly involved in the development for over a decade,” says AB-CT’s CEO, Dr. Ulrich Bergmoser.

• Oliver Dietrich assumes the role of Chief Market Officer (CMO), leveraging his extensive experience in national and international medical technology sales.

“With the broad range of competences of the newly established management team, our agile technology company is well geared to mastering the diverse challenges of the exciting medical technology market,” Dr. Bergmoser is convinced.

• The management team is backed by a strong advisory board including Prof. Dr. Rüdiger Schulz-Wendtland, Prof. Dr. Patricia Oppelt, Prof. Dr. Joachim Hornegger, and Dr. Dr. Dirk Knüppel.
• Benjamin Kalender, now in an advisory capacity, chairs the board.

“I am pleased that we have been able to recruit such outstanding personalities and talent for the new advisory board of AB-CT”, Kalender explains.

AB-CT thanks Benjamin Kalender and warmly welcomes new members.

Together, we’re committed to advancing breast imaging and delivering top-notch patient care.

Press release

In this article published by DIEurope, the University Hospital Erlangen introduces nu:view breast CT, which is in clinical use since 2019.

Dr. Matthias Wetzl, Dr. Sabine Ohlmeyer and Dr. Evelyn Wenkel describe recent clinical findings and give a profound insight into
➔ the photon-counting technology and the resulting advantages for image quality.
➔ and the possible indications for breast CT like problem-solving, preoperative staging and screening.

“Breast CT is so far the only 3D breast imaging method that has been shown to reliably detect micro­calcifications and mass lesions with­out any risk of obscuring lesions because of superimposed tissue.”

Read the whole article

AB-CT – Advanced Breast-CT will attend this year’s annual meeting of the German Senological Society (DGS e. V.) together with our partner Examion.

This event focuses on innovative and well-proven diagnostic and therapeutic methods. Experts from multiple disciplines will present the most modern techniques in clinical practice.

Visit uns in Munich and learn more about pioneering breast imaging: Thinking women.

• 42. Tagung der Deutschen Gesellschaft für Senologie e.V.
• 06. – 08. July 2023
• ICM Internationales Congress Center Munich

AB-CT are delighted to announce their partnership with MediLife UK

This marks an important step in AB-CT’s journey as we introduce nu:view to the UK and Ireland market.

MediLife are a UK based company who specialise in supporting the introduction of innovative medical technology to improve healthcare delivery and overall patient outcomes.

MediLife have an established network in breast radiology and a highly experienced team, making them the ideal partner for AB-CT.

We look forward to UK clinicians and patients experiencing quality diagnostics with the world’s first photon-counting breast CT.

As the second location of a nu:view in the Netherlands, Martini Hospital (Martini Ziekenhuis) has now taken breast diagnostics to a new level in Groningen.

The response and strong public interest in the Netherlands has been overwhelming.

Our innovative technology and its potential impact on healthcare have attracted the attention of professionals, patients and the public alike. A variety of Dutch media platforms were reporting on the new breast imaging technology at Martini Hospital.

We are looking forward to an exciting collaboration with the Martini Hospital and will keep you informed about new findings, successes and experiences.

Want to practice some Dutch? Here is a selection of the online publications about nu:view in Groningen.

Join us in Wiesbaden for the 104th Deutsche Röntgenkongress!

Right on the opening day we recommend to visit the scientific session “Mamma Diagnostics IV – News on CT” (Mammadiagnostik IV – Neues zum CT) and learn more about photon counting spiral breast CT:

First experiences with photon counting breast CT for the detection of microcalcifications.
(Erste Erfahrungen mit dem Photon-Counting-CT der Brust zur Erkennung von Mikroverkalkungen”
Luisa Huck from Aachen describes her first experiences with breast CT regarding the assessments of microcalcifications in comparison to digital tomosynthesis.

Explorative multicentre study to evaluate patient comfort, image quality and usability of dedicated spiral CT of the breast.
(Explorative Multicenterstudie zur Beurteilung des Patientenkomforts, der Bildqualität und der Benutzerfreundlichkeit der dedizierten Spiral-CT der Brust).
In this presentation, Matthias Wetzl from Erlangen reviews study results from several radiological institutions regarding image quality, a usability and patient comfort.

We are looking forward to an inspiring exchange. Contact us to get in touch: ask@crm.ab-ct.com

AB-CT @ 104. Deutscher Röntgenkongress (RÖKO) | South Hall, booth #47
Wednesday, 17.05.2023 – Friday, 19.05.2023
RheinMain CongressCenter (RMCC), Wiesbaden, Germany

nu:view breast CT allows for high-resolution 3D imaging without breast compression, combining cutting-edge imaging capabilities with patient experience. But what about the radiation dose?

In a retrospective study with 1657 breast CT examinations (829 patients), it was shown that radiation exposure of an examination using spiral breast CT equipped with a photon-counting detector [nu:view system] was lower than in diagnostic mammography and cone-beam breast CT. While other dose studies only examine phantoms, this is the first patient-specific dose study using real breast CT patient data from a large patient cohort.

After a dedicated breast tissue segmentation, a Monte Carlo simulation for dose estimation was performed and mathematical models which allow for an estimation of the dose based on morphological features were applied. Breast length was found to be an easy-to-use feature, which could be used by clinicians to adjust the scan settings to further minimize dose levels.

Full publication (paywall article):
Shim, S, Kolditz, D, Steiding, C, et al. Radiation dose estimates based on Monte Carlo simulation for spiral breast computed tomography imaging in a large cohort of patients. Med Phys. 2023; 1-12. https://doi.org/10.1002/mp.16211

Dedicated spiral breast CT with photon-counting technology (“nu:view” system) shows to be “a promising new breast imaging modality for several reasons”, finds a team of radiology scientists at the University Hospital Erlangen, Germany.

Summarising on previously published scientific investigations and their own 3-year clinical experience with the system, the concepts of spiral breast CT and potential implications for patient care are outlined. According to the authors, two main application areas for spiral breast CT are emerging:

• Advanced diagnostics: Contrast-enhanced spiral breast CT can provide functional information and may become an alternative to breast MRI in certain clinical settings, including problem-solving and staging.
• Reaching out to women: Used without contrast media, spiral breast CT can be considered as an alternative to DBT and might become an alternative to screening mammography in cases where women would otherwise refuse or not be able to undergo breast compression.

Accurate 3D assessment of microcalcifications and non-mass enhancement at high isotropic resolutions are seen as one strength of spiral breast CT, suggesting a “high diagnostic potential for the work-up of DCIS and its benign mimicker.”

Read the full review article (open access) to learn more:

M. Wetzl, M. Dietzel, S. Ohlmeyer, M. Uder, E. Wenkel. „Spiral breast computed tomography with a photon-counting detector (SBCT): The future of breast imaging?“ In: European Journal of Radiology 157 (2022), p. 110605. DOI: https://doi.org/10.1016/j.ejrad.2022.110605

As part of the expansion strategy, AB-CT’s shareholders have appointed Dr. Ulrich Bergmoser as the company’s new Co-CEO and CFO. “Dr. Bergmoser has a wealth of experience as CEO, CFO and strategic advisor in the healthcare sector that we are going to leverage to strengthen our processes and generate sustainable growth. Together, we will progress to the next stage and make breast CT more readily available,” says CEO Benjamin Kalender.

Dr. Ulrich Bergmoser: “AB-CT is an exceptionally innovative medtech company with a truly revolutionary technology. I am very much looking forward to being part of its further success story.”

Full press release (PDF, German):
AB-CT – Advanced Breast-CT GmbH mit Sitz in Erlangen hat im Rahmen der Expansionsstrategie Dr. Ulrich Bergmoser als Co-CEO und CFO gewonnen

What a (science) night! For the first time ever, the University Hospital Erlangen opened their doors to present their breast CT to a broader, non-medical audience during the “Lange Nacht der Wissenschaften”. It was a huge success.

In a series of 30 minutes guided tours, senior radiologist and head of diagnostic and interventional breast diagnostics Prof. Evelyn Wenkel and radiologist Dr. Matthias Wetzl took the groups on an insightful journey through today’s challenges and possibilities of breast cancer diagnostics.

After a brief introduction to breast CT, visitors could try the lying position that patients take during an examination for themselves. The interactive experience was followed by a demonstration of selected clinical cases that showed where and how breast CT is used to help with breast cancer diagnostics.

“’Maybe benign’ doesn’t help the woman,” Dr. Wetzl pointed out. What patients need is a diagnosis that’s as reliable possible, as quick as possible. The high-resolution 3D images are also used to determine the size of a tumour – relevant to make an informed decision whether full breast removal is necessary or if the route for breast-conserving surgical treatment can be taken.

Thank you very much to Prof. Wenkel and Dr. Wetzl for this informative insight behind the scenes, and to all visitors for their interest. We genuinely value such positive feedback.

AB-CT featuring @b-rayZ: Two breast health pioneers are combining their expertise in a project to the benefit of breast cancer patients and breast specialists.

The goal was the development of an AI platform for automatic analysis of spiral breast CT datasets in terms of image quality, glandular density, and detection of suspicious or cancerous lesions.

This Diagnostic Imaging Europe article not only explains the benefits of breast CT compared to standard examination methods, but highlights how AI can be integrated game changing into the examination process to improve workflow efficiency and overall patient care.

Source: DIEurope (Spring 2022), p. 26-27.